June 2023
Volume 64, Issue 8
Open Access
ARVO Annual Meeting Abstract  |   June 2023
Extracellular Vesicles in Diabetic Retinopathy
Author Affiliations & Notes
  • Julia V. Busik
    Physiology, Michigan State University, East Lansing, Michigan, United States
  • Footnotes
    Commercial Relationships   Julia Busik Ceramedix, Inc., Code C (Consultant/Contractor), Michigan State University, Code P (Patent), Ceramedix, Inc., Code S (non-remunerative)
  • Footnotes
    Support  R01EY025383, R01EY016077, R01EY028049, and R01EY030766.
Investigative Ophthalmology & Visual Science June 2023, Vol.64, 1944. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Julia V. Busik; Extracellular Vesicles in Diabetic Retinopathy. Invest. Ophthalmol. Vis. Sci. 2023;64(8):1944.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Presentation Description : Several studies have implicated the complement system in the development of vascular damage and progression of diabetic retinopathy. There is a link between membrane attack complex (MAC) deposition in the retina and the progression of DR. Extracellular vesicles (EVs), small vesicles that are secreted into the extracellular environment, have a cargo of complement proteins in plasma, suggesting that they can participate in causing the vascular damage associated with DR. We demonstrate that IgG-laden EVs in plasma activate the classical complement pathway and that the quantity of these EVs is increased in diabetes. Moreover, EVs in Streptozotocin (STZ)-induced rat diabetic plasma results in MAC deposition and cytolytic damage in human retinal endothelial cells (HRECs). Removal of the plasma EVs reduced the MAC deposition and abrogated cytolytic damage seen in HRECs. Similarly, lack of IgG in EVs in diabetic mice results in a reduction in retinal vascular damage in STZ induced mouse model.
Together, the results of this study demonstrate that complement activation by IgG-laden EVs in plasma could lead to MAC deposition and contribute to endothelium damage and progression of DR.

This abstract was presented at the 2023 ARVO Annual Meeting, held in New Orleans, LA, April 23-27, 2023.

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×